Nxera Pharma Co., Ltd. (TYO:4565)

Nxera Pharma Ratios and Metrics

Market cap in millions JPY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 5, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	74,839	94,216	127,103	175,151	155,210	145,054
Market Cap Growth	-14.18%	-25.87%	-27.43%	12.85%	7.00%	-13.29%
Enterprise Value	109,518	114,757	158,025	143,645	134,496	123,808
Last Close Price	827.00	1048.00	1421.00	2138.00	1904.00	1800.00
PE Ratio	-	-	-	458.51	152.62	98.08
Forward PE	18.36	48.75	62.51	62.98	37.67	87.15
PS Ratio	2.61	3.27	9.96	11.25	8.76	16.41
PB Ratio	1.14	1.38	1.90	3.02	2.70	2.77
P/TBV Ratio	-	-	-	5.14	4.67	5.49
P/FCF Ratio	-	-	-	18.10	22.49	31.67
P/OCF Ratio	-	-	-	17.60	21.88	31.05
EV/Sales Ratio	3.82	3.98	12.38	9.23	7.59	14.00
EV/EBITDA Ratio	-	-	-	34.56	16.43	56.17
EV/EBIT Ratio	-	-	-	51.08	19.46	144.97
EV/FCF Ratio	-7.84	-	-	14.85	19.49	27.03
Debt / Equity Ratio	0.96	0.99	1.11	0.51	0.51	0.32
Debt / EBITDA Ratio	-	-	-	7.15	3.57	7.54
Debt / FCF Ratio	-	-	-	3.07	4.24	3.63
Asset Turnover	0.19	0.19	0.10	0.16	0.20	0.13
Inventory Turnover	1.47	1.30	-	-	-	-
Quick Ratio	2.34	3.04	3.55	16.90	8.67	13.96
Current Ratio	3.14	3.70	3.79	17.09	8.73	14.08
Return on Equity (ROE)	-9.21%	-7.15%	-11.53%	0.66%	1.85%	3.03%
Return on Assets (ROA)	-3.58%	-2.68%	-5.07%	1.79%	4.98%	0.80%
Return on Invested Capital (ROIC)	-8.57%	-6.90%	-18.43%	4.17%	24.83%	2.57%
Return on Capital Employed (ROCE)	-6.60%	-4.90%	-7.40%	2.90%	7.70%	1.20%
Earnings Yield	-8.21%	-5.13%	-5.66%	0.22%	0.66%	1.02%
FCF Yield	-18.66%	-8.75%	-4.78%	5.52%	4.45%	3.16%
Buyback Yield / Dilution	-2.21%	-8.74%	0.09%	-0.71%	-3.16%	-2.60%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.